Core Scientific, Inc.
NASDAQ:CORZSoftware - Infrastructure
+$0.30 today
- Market cap
- $4.35B
- Beta
- 5.48
- P/E (TTM)
- -7.5
- EPS (TTM)
- -$3.77
Volume 11.93M
Average 13.68M
CORZ Accounts Payables
Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.
Core Scientific, Inc.NASDAQ: CORZ
Accounts Payables · Q3 FY2026 · quarter ended Sep 2026
Accounts payables growth accelerates
Q3 FY2026 accounts payables of $46.58M (cash outflow) rose 3659.7% year over year, ahead of the +194.7% change in trailing-twelve-month accounts payables. Sequentially, it rose 12.3% from the prior quarter. Over 3 fiscal years it compounded at -26.1% a year.
Context
- Accounts payables amounted to 3.4% of revenue in FY2025, up 1.0 pp from a year earlier.
- Accounts payables increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +3659.7% holds above the trailing-twelve-month pace of +194.7%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Payables history
USD · from the cash flow
- Latest · FY2025
- 10.78M USD
- Year-over-year change
- +187.9%
| Period | Period end | Accounts Payables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 10.78M | +187.9% |
| FY2024 | 2024-12-31 | (12.27M) | -110.3% |
| FY2023 | 2023-12-31 | 118.6M | +344.0% |
| FY2022 | 2022-12-31 | 26.71M | +221.5% |
| FY2021 | 2021-12-31 | (21.99M) | — |
Accounts Payables vs competitors
How CORZ compares with its peers on the latest reported figures
- CORZ's LTM Sep 2026 accounts payables of $53.78M is the 2nd largest of the 5 companies compared; the peer median is $60.3K.
- Its year-over-year change of +194.7% is the highest of 4, against a peer median of -61.5%.
- Accounts payables amounts to 9.1% of revenue for CORZ, versus a peer median of 4.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Aug 2026 | $68.62M | +187.4% | -55.9% | 8.0% | |
| LTM Sep 2026 | $53.78M | +194.7% | -26.1% | 9.1% | |
ABTCAmerican Bitcoin Corp | LTM Mar 2026 | $24M | -3480.4% | +309.3% | 11.6% |
DTCXDatacentrex, Inc. | LTM Mar 2026 | $120.59K | -61.5% | +87.2% | 1.3% |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding CORZ) | $60.3K | -61.5% | +87.2% | 4.7% | |
Competitors are the stored peer set for CORZ. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 47.31M | (2.15B) | (246.49M) | (1.32B) | (288.62M) |
| Depreciation & Amortization | 33.36M | 226.09M | 96.45M | 120.12M | 80.18M |
| Deferred Income Tax | 9.53M | (18.52M) | 0 | 0 | 0 |
| Stock-Based Compensation | 38.94M | 182.89M | 58.89M | 51.92M | 98.24M |
| Change in Working Capital | (49.52M) | 78.61M | 551.03M | (27.64M) | 524.53M |
| Accounts Receivables | (7.41M) | (7.58M) | (744K) | 659K | 16.22M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | (21.99M) | 26.71M | 118.6M | (12.27M) | 10.78M |
| Other Working Capital | (20.12M) | 59.47M | 433.18M | (16.02M) | 497.53M |
| Other Non-Cash Items | (136.36M) | 1.88B | (394.77M) | 1.21B | (136.08M) |
| Operating Cash Flow | (56.74M) | 205.19M | 65.11M | 42.9M | 278.25M |
| Capital Expenditures | (59.28M) | (601.66M) | (16.16M) | (94.96M) | (729M) |
| Acquisitions (Net) | (365.21M) | 10.85M | 0 | 0 | 0 |
| Purchases of Investments | (59.28M) | 0 | 0 | 0 | (5M) |
| Sales of Investments | 0 | 10.85M | 0 | 0 | 0 |
| Other Investing Activities | 345.65M | (10.82M) | 13.17M | (231K) | (6.75M) |
| Investing Cash Flow | (423.84M) | (590.78M) | (3M) | (95.19M) | (740.75M) |
| Debt Repayment | 613.7M | 117.74M | (40.99M) | 766.91M | (10.29M) |
| Common Stock Issued | 671.26M | 0 | 0 | 55M | 6.91M |
| Common Stock Repurchased | 0 | (31.65M) | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (681.43M) | 220.06M | (3.66M) | (2.34M) | (59.73M) |
| Financing Cash Flow | 603.53M | 306.15M | (44.65M) | 819.57M | (63.1M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 122.96M | (79.44M) | 17.47M | 767.27M | (525.6M) |
| Free Cash Flow | (116.01M) | (396.47M) | 48.95M | (52.07M) | (450.75M) |
Core Scientific, Inc.
NASDAQ:CORZ
Intrinsic Alpha fair value
Locked
Current Price
$13.51
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.